Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Multiple sclerosis (Ponesimod - Multiple sclerosis)

Records returned : 23 (on 29 May 2025 at 10:56:29). Return to search results for ' Multiple sclerosis '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Ponesimod

Drug:

Ponesimod

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

2. Alemtuzumab

Drug:

Alemtuzumab

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Intravenous infusion

Restrictions / Comments:

Important

ASPH are the only Surrey Heartlands Trust commissioned to provide this.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

3. Cladribine

Drug:

Cladribine

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

4. Dimethyl fumarate

Drug:

Dimethyl fumarate

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Capsules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

5. Diroximal fumarate

Drug:

Diroximal fumarate

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

6. Fampridine

Drug:

Fampridine

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Modified release tablets

Restrictions / Comments:

Important

Specialist centre only

Commissioned by NHSE from specialist centres only.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

7. Fingolimod

Drug:

Fingolimod

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Capsules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

8. Glatiramer acetate

Drug:

Glatiramer acetate

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

9. Interferon beta

Drug:

Interferon beta

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

10. Modafinil

Drug:

Modafinil

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Important

Safety in pregnancy warnings.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

11. Natalizumab

Drug:

Natalizumab

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Intravenous infusion

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

12. Ocrelizumab

Drug:

Ocrelizumab

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Infusion

Restrictions / Comments:

Important

ASPH are the only Surrey Heartlands Trust commissioned to provide this.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

13. Ofatumumab

Drug:

Ofatumumab

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Subcutaneous injection (sc)

Restrictions / Comments:

Important

ASPH are the only Surrey Heartlands Trust commissioned to provide this.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

14. Ozanimod

Drug:

Ozanimod

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Capsules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

15. Peginterferon beta-1a

Drug:

Peginterferon beta-1a

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Subcutaneous injection (sc)

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

16. Siponimod

Drug:

Siponimod

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

17. Teriflunomide

Drug:

Teriflunomide

Indication :

Multiple sclerosis

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

NICE

18. Biotin

Drug:

Biotin

Indication :

Multiple sclerosis

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Important

NHSE Specialist Commissioned Services only. Not commissioned from any Surrey Heartlands Trusts.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NHSE

19. Donepezil hydrochloride

Drug:

Donepezil hydrochloride

Indication :

Multiple sclerosis

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

20. Galantamine

Drug:

Galantamine

Indication :

Multiple sclerosis

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

21. Memantine hydrochloride

Drug:

Memantine hydrochloride

Indication :

Multiple sclerosis

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

22. Naltrexone hydrochloride

Drug:

Naltrexone hydrochloride

Indication :

Multiple sclerosis

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

23. Rivastigmine

Drug:

Rivastigmine

Indication :

Multiple sclerosis

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1